Non-Genetically Encoded Epitopes Are Relevant Targets in Autoimmune Diabetes
- PMID: 33671312
- PMCID: PMC7922826
- DOI: 10.3390/biomedicines9020202
Non-Genetically Encoded Epitopes Are Relevant Targets in Autoimmune Diabetes
Abstract
Islet antigen reactive T cells play a key role in promoting beta cell destruction in type 1 diabetes (T1D). Self-reactive T cells are typically deleted through negative selection in the thymus or deviated to a regulatory phenotype. Nevertheless, those processes are imperfect such that even healthy individuals have a reservoir of potentially autoreactive T cells. What remains less clear is how tolerance is lost to insulin and other beta cell specific antigens. Islet autoantibodies, the best predictor of disease risk, are known to recognize classical antigens such as proinsulin, GAD65, IA-2, and ZnT8. These antibodies are thought to be supported by the expansion of autoreactive CD4+ T cells that recognize these same antigenic targets. However, recent studies have identified new classes of non-genetically encoded epitopes that may reflect crucial gaps in central and peripheral tolerance. Notably, some of these specificities, including epitopes from enzymatically post-translationally modified antigens and hybrid insulin peptides, are present at relatively high frequencies in the peripheral blood of patients with T1D. We conclude that CD4+ T cells that recognize non-genetically encoded epitopes are likely to make an important contribution to the progression of islet autoimmunity in T1D. We further propose that these classes of neo-epitopes should be considered as possible targets for strategies to induce antigen specific tolerance.
Keywords: T cell; neo-antigen; post-translational modification; selection; type 1 diabetes.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures


Similar articles
-
T cell epitopes and post-translationally modified epitopes in type 1 diabetes.Curr Diab Rep. 2015 Nov;15(11):90. doi: 10.1007/s11892-015-0657-7. Curr Diab Rep. 2015. PMID: 26370701 Free PMC article. Review.
-
Characterizing T cell responses to enzymatically modified beta cell neo-epitopes.Front Immunol. 2023 Jan 10;13:1015855. doi: 10.3389/fimmu.2022.1015855. eCollection 2022. Front Immunol. 2023. PMID: 36703975 Free PMC article.
-
Analysis of pancreatic beta cell specific CD4+ T cells reveals a predominance of proinsulin specific cells.Cell Immunol. 2019 Jan;335:68-75. doi: 10.1016/j.cellimm.2018.11.004. Epub 2018 Nov 7. Cell Immunol. 2019. PMID: 30428974
-
Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes.Front Endocrinol (Lausanne). 2017 Sep 29;8:262. doi: 10.3389/fendo.2017.00262. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 29033899 Free PMC article.
-
Narrowing in on the anti-β cell-specific T cells: looking 'where the action is'.Curr Opin Endocrinol Diabetes Obes. 2017 Apr;24(2):98-102. doi: 10.1097/MED.0000000000000323. Curr Opin Endocrinol Diabetes Obes. 2017. PMID: 28099204 Free PMC article. Review.
Cited by
-
Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes.Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2110987119. doi: 10.1073/pnas.2110987119. Epub 2022 Apr 6. Proc Natl Acad Sci U S A. 2022. PMID: 35385352 Free PMC article.
-
The beta cell-immune cell interface in type 1 diabetes (T1D).Mol Metab. 2023 Dec;78:101809. doi: 10.1016/j.molmet.2023.101809. Epub 2023 Sep 20. Mol Metab. 2023. PMID: 37734713 Free PMC article. Review.
-
ADAR1-dependent editing regulates human β cell transcriptome diversity during inflammation.Front Endocrinol (Lausanne). 2022 Nov 28;13:1058345. doi: 10.3389/fendo.2022.1058345. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36518246 Free PMC article.
-
Recognition of mRNA Splice Variant and Secretory Granule Epitopes by CD4+ T Cells in Type 1 Diabetes.Diabetes. 2023 Jan 1;72(1):85-96. doi: 10.2337/db22-0191. Diabetes. 2023. PMID: 36201618 Free PMC article.
-
Found in Translation: Novel Insights Into Type 1 Diabetes and β-Cell Biology.Diabetes. 2021 Oct;70(10):2185-2186. doi: 10.2337/dbi21-0031. Diabetes. 2021. PMID: 34593539 Free PMC article. No abstract available.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials